UniProt ID | THRB_HUMAN | |
---|---|---|
UniProt AC | P00734 | |
Protein Name | Prothrombin | |
Gene Name | F2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 622 | |
Subcellular Localization | Secreted, extracellular space. | |
Protein Description | Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing.. | |
Protein Sequence | MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
49 | Gamma-carboxyglutamic_acid | RRANTFLEEVRKGNL HHHHHHHHHHHCCCC | 50.70 | 3759958 | |
49 | 4-carboxyglutamate | RRANTFLEEVRKGNL HHHHHHHHHHHCCCC | 50.70 | - | |
49 | Gamma-carboxyglutamic_acid | RRANTFLEEVRKGNL HHHHHHHHHHHCCCC | 50.70 | 6305407 | |
50 | Gamma-carboxyglutamic_acid | RANTFLEEVRKGNLE HHHHHHHHHHCCCCH | 50.17 | 3759958 | |
50 | Gamma-carboxyglutamic_acid | RANTFLEEVRKGNLE HHHHHHHHHHCCCCH | 50.17 | 6305407 | |
50 | 4-carboxyglutamate | RANTFLEEVRKGNLE HHHHHHHHHHCCCCH | 50.17 | - | |
57 | Gamma-carboxyglutamic_acid | EVRKGNLERECVEET HHHCCCCHHHHHHHH | 50.89 | 6305407 | |
57 | Gamma-carboxyglutamic_acid | EVRKGNLERECVEET HHHCCCCHHHHHHHH | 50.89 | 6305407 | |
57 | 4-carboxyglutamate | EVRKGNLERECVEET HHHCCCCHHHHHHHH | 50.89 | - | |
59 | Gamma-carboxyglutamic_acid | RKGNLERECVEETCS HCCCCHHHHHHHHCC | 33.27 | 6305407 | |
59 | 4-carboxyglutamate | RKGNLERECVEETCS HCCCCHHHHHHHHCC | 33.27 | - | |
59 | Gamma-carboxyglutamic_acid | RKGNLERECVEETCS HCCCCHHHHHHHHCC | 33.27 | 6305407 | |
62 | Gamma-carboxyglutamic_acid | NLERECVEETCSYEE CCHHHHHHHHCCHHH | 60.28 | 6305407 | |
62 | Gamma-carboxyglutamic_acid | NLERECVEETCSYEE CCHHHHHHHHCCHHH | 60.28 | 6305407 | |
62 | 4-carboxyglutamate | NLERECVEETCSYEE CCHHHHHHHHCCHHH | 60.28 | - | |
63 | 4-carboxyglutamate | LERECVEETCSYEEA CHHHHHHHHCCHHHH | 34.42 | - | |
63 | Gamma-carboxyglutamic_acid | LERECVEETCSYEEA CHHHHHHHHCCHHHH | 34.42 | 6305407 | |
63 | Gamma-carboxyglutamic_acid | LERECVEETCSYEEA CHHHHHHHHCCHHHH | 34.42 | 6305407 | |
68 | 4-carboxyglutamate | VEETCSYEEAFEALE HHHHCCHHHHHHHHH | 26.93 | - | |
68 | Gamma-carboxyglutamic_acid | VEETCSYEEAFEALE HHHHCCHHHHHHHHH | 26.93 | 6305407 | |
68 | Gamma-carboxyglutamic_acid | VEETCSYEEAFEALE HHHHCCHHHHHHHHH | 26.93 | 6305407 | |
69 | 4-carboxyglutamate | EETCSYEEAFEALES HHHCCHHHHHHHHHC | 50.88 | - | |
69 | Gamma-carboxyglutamic_acid | EETCSYEEAFEALES HHHCCHHHHHHHHHC | 50.88 | 6305407 | |
69 | Gamma-carboxyglutamic_acid | EETCSYEEAFEALES HHHCCHHHHHHHHHC | 50.88 | 6305407 | |
72 | 4-carboxyglutamate | CSYEEAFEALESSTA CCHHHHHHHHHCCCH | 60.43 | - | |
72 | Gamma-carboxyglutamic_acid | CSYEEAFEALESSTA CCHHHHHHHHHCCCH | 60.43 | 6305407 | |
72 | Gamma-carboxyglutamic_acid | CSYEEAFEALESSTA CCHHHHHHHHHCCCH | 60.43 | 6305407 | |
75 | 4-carboxyglutamate | EEAFEALESSTATDV HHHHHHHHCCCHHHH | 50.09 | - | |
75 | Gamma-carboxyglutamic_acid | EEAFEALESSTATDV HHHHHHHHCCCHHHH | 50.09 | 6305407 | |
75 | Gamma-carboxyglutamic_acid | EEAFEALESSTATDV HHHHHHHHCCCHHHH | 50.09 | 6305407 | |
78 | O-linked_Glycosylation | FEALESSTATDVFWA HHHHHCCCHHHHHHH | 42.74 | OGP | |
121 | N-linked_Glycosylation | TNYRGHVNITRSGIE CCCCCCEEEECCCEE | 25.00 | 22171320 | |
121 | N-linked_Glycosylation | TNYRGHVNITRSGIE CCCCCCEEEECCCEE | 25.00 | 16335952 | |
125 | Phosphorylation | GHVNITRSGIECQLW CCEEEECCCEEEEEE | 35.16 | 24505115 | |
134 | Phosphorylation | IECQLWRSRYPHKPE EEEEEEHHCCCCCCC | 25.28 | 24505115 | |
143 | N-linked_Glycosylation | YPHKPEINSTTHPGA CCCCCCCCCCCCCCC | 31.48 | 22171320 | |
143 | N-linked_Glycosylation | YPHKPEINSTTHPGA CCCCCCCCCCCCCCC | 31.48 | 16335952 | |
144 | Phosphorylation | PHKPEINSTTHPGAD CCCCCCCCCCCCCCC | 40.10 | 24505115 | |
145 | O-linked_Glycosylation | HKPEINSTTHPGADL CCCCCCCCCCCCCCH | 25.33 | OGP | |
192 | O-linked_Glycosylation | VCGQDQVTVAMTPRS CCCCCEEEEEECCCC | 9.27 | OGP | |
196 | O-linked_Glycosylation | DQVTVAMTPRSEGSS CEEEEEECCCCCCCC | 13.05 | OGP | |
199 | O-linked_Glycosylation | TVAMTPRSEGSSVNL EEEECCCCCCCCCCC | 47.73 | OGP | |
199 | Phosphorylation | TVAMTPRSEGSSVNL EEEECCCCCCCCCCC | 47.73 | 24505115 | |
202 | Phosphorylation | MTPRSEGSSVNLSPP ECCCCCCCCCCCCCC | 27.36 | 24505115 | |
203 | Phosphorylation | TPRSEGSSVNLSPPL CCCCCCCCCCCCCCH | 26.36 | 24505115 | |
207 | Phosphorylation | EGSSVNLSPPLEQCV CCCCCCCCCCHHHCC | 21.19 | 24275569 | |
207 | O-linked_Glycosylation | EGSSVNLSPPLEQCV CCCCCCCCCCHHHCC | 21.19 | OGP | |
315 | O-linked_Glycosylation | DRAIEGRTATSEYQT HHHHCCCCCCCCCCC | 45.18 | OGP | |
317 | O-linked_Glycosylation | AIEGRTATSEYQTFF HHCCCCCCCCCCCCC | 22.83 | OGP | |
317 | Phosphorylation | AIEGRTATSEYQTFF HHCCCCCCCCCCCCC | 22.83 | 24505115 | |
318 | Phosphorylation | IEGRTATSEYQTFFN HCCCCCCCCCCCCCC | 31.66 | 24505115 | |
320 | Phosphorylation | GRTATSEYQTFFNPR CCCCCCCCCCCCCCC | 16.78 | - | |
331 | Phosphorylation | FNPRTFGSGEADCGL CCCCCCCCCCCCCCC | 29.30 | 24505115 | |
416 | N-linked_Glycosylation | LYPPWDKNFTENDLL HCCCCCCCCCCCCEE | 46.75 | 18638581 | |
434 | Phosphorylation | GKHSRTRYERNIEKI CCCCCCHHHHHHHHH | 20.73 | - | |
539 | Phosphorylation | ERPVCKDSTRIRITD ECCCCCCCCEEEEEC | 12.70 | 20068231 | |
540 | Phosphorylation | RPVCKDSTRIRITDN CCCCCCCCEEEEECC | 40.00 | 20068231 | |
553 | Nitration | DNMFCAGYKPDEGKR CCEEECCCCCCCCCC | 10.79 | - | |
599 | Acetylation | EGCDRDGKYGFYTHV CCCCCCCCCEEEHHH | 46.63 | 30591549 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of THRB_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of THRB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
143 | N-linked Glycosylation | 149 (6) | T ⇒ R;M | rs5896 |
| 29617998 |
143 | N-linked Glycosylation | 149 (6) | T ⇒ R;M | rs5896 |
| 29617998 |
153 | N-linked Glycosylation | 149 (4) | T ⇒ R;M | rs5896 |
| 29617998 |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PAI1_HUMAN | SERPINE1 | physical | 12709053 | |
FIBA_HUMAN | FGA | physical | 1587268 | |
HEP2_HUMAN | SERPIND1 | physical | 12169660 | |
CBPB2_HUMAN | CPB2 | physical | 8663147 | |
TRBM_HUMAN | THBD | physical | 8663147 | |
FA5_HUMAN | F5 | physical | 9032460 | |
IC1_HUMAN | SERPING1 | physical | 11460008 | |
F10A1_HUMAN | ST13 | physical | 11687574 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
613679 | Factor II deficiency (FA2D) | |||||
601367 | Ischemic stroke (ISCHSTR) | |||||
188050 | Thrombophilia due to thrombin defect (THPH1) | |||||
614390 | Pregnancy loss, recurrent, 2 (RPRGL2) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Human urinary glycoproteomics; attachment site specific analysis ofN-and O-linked glycosylations by CID and ECD."; Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.; Mol. Cell. Proteomics 0:0-0(2011). Cited for: GLYCOSYLATION AT ASN-121 AND ASN-143, STRUCTURE OF CARBOHYDRATES, ANDMASS SPECTROMETRY. | |
"Enrichment of glycopeptides for glycan structure and attachment siteidentification."; Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,Brinkmalm G., Larson G.; Nat. Methods 6:809-811(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-416, CARBOHYDRATESTRUCTURE, AND MASS SPECTROMETRY. | |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-416, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-121; ASN-143 AND ASN-416,AND MASS SPECTROMETRY. | |
"Screening for N-glycosylated proteins by liquid chromatography massspectrometry."; Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.; Proteomics 4:454-465(2004). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-121 AND ASN-143, AND MASSSPECTROMETRY. |